Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has updated the contact details section for the study, replacing the previous information with new details and clarifying where the study is taking place.
    Difference
    3%
    Check dated 2024-12-07T16:43:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Recent updates include new entries for November 2024, while previous updates from July 2024 have been removed.
    Difference
    0.5%
    Check dated 2024-11-30T14:50:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    4%
    Check dated 2024-11-23T05:02:42.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Several key resources related to rare diseases and clinical trials have been removed, including links to NIH and Dailymed, which may impact access to important medical information.
    Difference
    0.5%
    Check dated 2024-11-16T00:19:19.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new additions including links to clinical trials, drug information, and resources from NIH and HHS, while the previous version 2.12.1 has been removed.
    Difference
    5%
    Check dated 2024-11-08T18:36:41.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:03:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.